- Home
- / Superluminal Medicines
Superluminal Medicines
Total Funding
$33 M
Superluminal Medicines Summary
Company Summary
- Overview
- Superluminal Medicines is a generative biology and chemistry company. It develops a drug screening platform that creates protein shapes and designs selective compounds for a therapeutic effect.
- Type
- Private
- Status
- Active
- Founded
- 2022
- HQ
- Boston, MA, US | view all locations
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Cony D'Cruz, Co-Founder & CEO
Marek Orzechowski, Senior Director, Computational Chemistry
Murco Ringnalda, SVP, Head of Operations
LocationsView all
1 location detected
Boston, MA HQ
United States
15 Necco St. Lilly Gateway Labs, 4th Floor